Used in pharmaceutical research as a kinase inhibitor, particularly showing activity against cyclin-dependent kinases (CDKs). It has been investigated for its potential in cancer therapy due to its ability to interfere with cell cycle progression and induce apoptosis in tumor cells. Its structure allows for strong binding to ATP sites in kinases, making it a lead compound in developing antiproliferative agents. Also explored for use in combination therapies to overcome drug resistance in solid tumors.